<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>NCPI-FHIR-IMPLEMENTATION-GUIDE\Disease Codes - FHIR v4.0.1</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"7.8"}
    h3,h4,h5,h6{--heading-prefix:"7.8"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->
        <!-- Placeholder for child template header declarations -->


        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">NCPI FHIR Implementation Guide</span><br/>0.1.0 - ci-build</p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">IG Home</a>
  </li>
  <li>
    <a href="toc.html">Table of Contents</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Background
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="background.html">NCPI FHIR</a>
      </li>
      <li>
        <a href="use_cases.html">Use Cases</a>
      </li>
      <li>
        <a href="authors.html">Authors</a>
      </li>
      <li>
        <a href="contact.html">Contact</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Support
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="http://hl7.org/fhir/R4/index.html">FHIR Spec</a>
      </li>
      <li>
        <a href="downloads.html">Downloads</a>
      </li>
    </ul>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>Disease Codes</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div class="col-12">
  <!--ReleaseHeader--><p id="publish-box">NCPI FHIR Implementation Guide - Local Development build (v0.1.0). See the <a href="https://ncpi-fhir.github.io/ncpi-fhir-ig/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->
  






<ul class="nav nav-tabs">

  <li class="active">
    <a href="#">Narrative Content</a>
  </li>


  
    <li>
      <a href="ValueSet-disease-codes.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="ValueSet-disease-codes.json.html">JSON</a>
    </li>
  


  
    <li>
      <a href="ValueSet-disease-codes.ttl.html">TTL</a>
    </li>
  



</ul>

  <a name="root"> </a>
  <h2 id="root">ValueSet: Disease Codes</h2>
  <p>
    <b>Summary</b>
  </p>
  <table class="grid">
<tbody>
<tr><td>Defining URL:</td><td>https://ncpi-fhir.github.io/ncpi-fhir-ig/ValueSet/disease-codes</td></tr>
 <tr><td>Version:</td><td>0.1.0</td></tr>
 <tr><td>Name:</td><td>DiseaseCodes</td></tr>
 <tr><td>Title:</td><td>Disease Codes</td></tr>
 <tr><td>Status:</td><td>Draft as of 2021-09-14T17:59:16+00:00</td></tr>
 <tr><td>Definition:</td><td><p>This value set includes all codes from this FHIR server's representation of OMIM, Mondo and NICt CodeSystems.</p>
</td></tr>
 <tr><td>Publisher:</td><td>NCPI FHIR Working Group</td></tr>
 <tr><td>Source Resource:</td><td><a href="ValueSet-disease-codes.xml.html">XML</a> / <a href="ValueSet-disease-codes.json.html">JSON</a> / <a href="ValueSet-disease-codes.ttl.html">Turtle</a></td></tr>
</tbody></table>


  <p>
    <b>References</b>
  </p>
  
<ul>
 <li><a href="StructureDefinition-disease.html">NCPI Disease</a></li>
</ul>


  <!-- insert intro if present -->
  



  <a name="definition"> </a>

<!-- Content Logical Definition heading in the fragment -->
  <h3>Logical Definition (CLD)</h3>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set includes codes based on the following rules:</p><ul><li>Include all codes defined in <a href="CodeSystem-omim.html"><code>https://omim.org/</code></a></li><li>Include all codes defined in <a href="CodeSystem-mondo.html"><code>http://purl.obolibrary.org/obo/mondo.owl</code></a></li><li>Include all codes defined in <a href="CodeSystem-ncit.html"><code>http://purl.obolibrary.org/obo/ncit.owl</code></a></li></ul></div>

  <p>&#160;</p>
  <a name="expansion"> </a>
  <h3 id="expansion">Expansion</h3>

  <div xmlns="http://www.w3.org/1999/xhtml"><p>This value set contains 504 concepts</p><div style="border: maroon 1px solid; background-color: #FFCCCC; padding: 8px"><p>Warning: this expansion is generated from fragments of the following code systems, and may be missing codes, or include codes that are not valid:</p><ul><li><a href="CodeSystem-omim.html">Online Mendelian Inheritance in Man</a></li><li><a href="CodeSystem-mondo.html">Mondo Disease Ontology</a></li><li><a href="CodeSystem-ncit.html">NCI Thesaurus</a></li></ul></div><div style="border: black 1px dotted; background-color: #EEEEEE; padding: 8px; margin-bottom: 8px"><p>Expansion based on: </p><ul><li><a href="CodeSystem-ncit.html">NCI Thesaurus v0.1.0 (CodeSystem)</a></li><li><a href="CodeSystem-omim.html">Online Mendelian Inheritance in Man v0.1.0 (CodeSystem)</a></li><li><a href="CodeSystem-mondo.html">Mondo Disease Ontology v0.1.0 (CodeSystem)</a></li></ul></div><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>System</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613801"> </a>OMIM:613801</td><td>https://omim.org/</td><td>Retinitis pigmentosa-40</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-213300"> </a>OMIM:213300</td><td>https://omim.org/</td><td>Joubert syndrome 1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615780"> </a>OMIM:615780</td><td>https://omim.org/</td><td>Retinitis pigmentosa 69</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613826"> </a>OMIM:613826</td><td>https://omim.org/</td><td>Leber congenital amaurosis 6</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-310200"> </a>OMIM:310200</td><td>https://omim.org/</td><td>Duchenne muscular dystrophy</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617194"> </a>OMIM:617194</td><td>https://omim.org/</td><td>Lethal congenital contracture syndrome 11</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-105400"> </a>OMIM:105400</td><td>https://omim.org/</td><td>AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-108120"> </a>OMIM:108120</td><td>https://omim.org/</td><td>ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-114300"> </a>OMIM:114300</td><td>https://omim.org/</td><td>ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-115195"> </a>OMIM:115195</td><td>https://omim.org/</td><td>CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-115196"> </a>OMIM:115196</td><td>https://omim.org/</td><td>CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-115197"> </a>OMIM:115197</td><td>https://omim.org/</td><td>CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-115200"> </a>OMIM:115200</td><td>https://omim.org/</td><td>CARDIOMYOPATHY, DILATED, 1A; CMD1A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-117000"> </a>OMIM:117000</td><td>https://omim.org/</td><td>CENTRAL CORE DISEASE OF MUSCLE; CCD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-117360"> </a>OMIM:117360</td><td>https://omim.org/</td><td>SPINOCEREBELLAR ATAXIA 29; SCA29</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-119530"> </a>OMIM:119530</td><td>https://omim.org/</td><td>OROFACIAL CLEFT 1; OFC1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-122470"> </a>OMIM:122470</td><td>https://omim.org/</td><td>CORNELIA DE LANGE SYNDROME 1; CDLS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-130600"> </a>OMIM:130600</td><td>https://omim.org/</td><td>ELLIPTOCYTOSIS 2; EL2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-135900"> </a>OMIM:135900</td><td>https://omim.org/</td><td>COFFIN-SIRIS SYNDROME 1; CSS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-136140"> </a>OMIM:136140</td><td>https://omim.org/</td><td>FLOATING-HARBOR SYNDROME; FLHS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-137920"> </a>OMIM:137920</td><td>https://omim.org/</td><td>RENAL CYSTS AND DIABETES SYNDROME; RCAD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-139090"> </a>OMIM:139090</td><td>https://omim.org/</td><td>GRAY PLATELET SYNDROME; GPS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-139210"> </a>OMIM:139210</td><td>https://omim.org/</td><td>MYHRE SYNDROME; MYHRS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-143095"> </a>OMIM:143095</td><td>https://omim.org/</td><td>SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-143465"> </a>OMIM:143465</td><td>https://omim.org/</td><td>ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-147891"> </a>OMIM:147891</td><td>https://omim.org/</td><td>ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION; ICPPS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-147920"> </a>OMIM:147920</td><td>https://omim.org/</td><td>KABUKI SYNDROME 1; KABUK1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-148050"> </a>OMIM:148050</td><td>https://omim.org/</td><td>KBG SYNDROME; KBGS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-149400"> </a>OMIM:149400</td><td>https://omim.org/</td><td>HYPEREKPLEXIA 1; HKPX1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-152950"> </a>OMIM:152950</td><td>https://omim.org/</td><td>MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-153670"> </a>OMIM:153670</td><td>https://omim.org/</td><td>BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-154400"> </a>OMIM:154400</td><td>https://omim.org/</td><td>ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-154700"> </a>OMIM:154700</td><td>https://omim.org/</td><td>MARFAN SYNDROME; MFS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-155310"> </a>OMIM:155310</td><td>https://omim.org/</td><td>VISCERAL MYOPATHY; VSCM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-158590"> </a>OMIM:158590</td><td>https://omim.org/</td><td>NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-158810"> </a>OMIM:158810</td><td>https://omim.org/</td><td>BETHLEM MYOPATHY 1; BTHLM1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-159550"> </a>OMIM:159550</td><td>https://omim.org/</td><td>ATAXIA-PANCYTOPENIA SYNDROME; ATXPC</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-160150"> </a>OMIM:160150</td><td>https://omim.org/</td><td>MYOPATHY, CENTRONUCLEAR, 1; CNM1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-160500"> </a>OMIM:160500</td><td>https://omim.org/</td><td>MYOPATHY, DISTAL, 1; MPD1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-160800"> </a>OMIM:160800</td><td>https://omim.org/</td><td>MYOTONIA CONGENITA, AUTOSOMAL DOMINANT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-160900"> </a>OMIM:160900</td><td>https://omim.org/</td><td>MYOTONIC DYSTROPHY 1; DM1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-161800"> </a>OMIM:161800</td><td>https://omim.org/</td><td>NEMALINE MYOPATHY 3; NEM3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-163950"> </a>OMIM:163950</td><td>https://omim.org/</td><td>NOONAN SYNDROME 1; NS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-178110"> </a>OMIM:178110</td><td>https://omim.org/</td><td>CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A; CPSFS1A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-178500"> </a>OMIM:178500</td><td>https://omim.org/</td><td>PULMONARY FIBROSIS, IDIOPATHIC; IPF</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-180100"> </a>OMIM:180100</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 1; RP1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-180849"> </a>OMIM:180849</td><td>https://omim.org/</td><td>RUBINSTEIN-TAYBI SYNDROME 1; RSTS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-181430"> </a>OMIM:181430</td><td>https://omim.org/</td><td>SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-182601"> </a>OMIM:182601</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-188000"> </a>OMIM:188000</td><td>https://omim.org/</td><td>THROMBOCYTOPENIA 2; THC2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-191480"> </a>OMIM:191480</td><td>https://omim.org/</td><td>UNCOMBABLE HAIR SYNDROME 1; UHS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-203800"> </a>OMIM:203800</td><td>https://omim.org/</td><td>ALSTROM SYNDROME; ALMS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-204200"> </a>OMIM:204200</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-204500"> </a>OMIM:204500</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-205100"> </a>OMIM:205100</td><td>https://omim.org/</td><td>AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-206900"> </a>OMIM:206900</td><td>https://omim.org/</td><td>MICROPHTHALMIA, SYNDROMIC 3; MCOPS3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-208900"> </a>OMIM:208900</td><td>https://omim.org/</td><td>ATAXIA-TELANGIECTASIA; AT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-209850"> </a>OMIM:209850</td><td>https://omim.org/</td><td>AUTISM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-209900"> </a>OMIM:209900</td><td>https://omim.org/</td><td>BARDET-BIEDL SYNDROME 1; BBS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-210000"> </a>OMIM:210000</td><td>https://omim.org/</td><td>BEHR SYNDROME; BEHRS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-210720"> </a>OMIM:210720</td><td>https://omim.org/</td><td>MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-210900"> </a>OMIM:210900</td><td>https://omim.org/</td><td>BLOOM SYNDROME; BLM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-212065"> </a>OMIM:212065</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-212066"> </a>OMIM:212066</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-214500"> </a>OMIM:214500</td><td>https://omim.org/</td><td>CHEDIAK-HIGASHI SYNDROME; CHS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-214800"> </a>OMIM:214800</td><td>https://omim.org/</td><td>CHARGE SYNDROME</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-215500"> </a>OMIM:215500</td><td>https://omim.org/</td><td>CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-216400"> </a>OMIM:216400</td><td>https://omim.org/</td><td>COCKAYNE SYNDROME A; CSA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-216550"> </a>OMIM:216550</td><td>https://omim.org/</td><td>COHEN SYNDROME; COH1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-217080"> </a>OMIM:217080</td><td>https://omim.org/</td><td>JALILI SYNDROME</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-217980"> </a>OMIM:217980</td><td>https://omim.org/</td><td>CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-218340"> </a>OMIM:218340</td><td>https://omim.org/</td><td>TEMTAMY SYNDROME; TEMTYS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-219200"> </a>OMIM:219200</td><td>https://omim.org/</td><td>CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-224050"> </a>OMIM:224050</td><td>https://omim.org/</td><td>CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-224690"> </a>OMIM:224690</td><td>https://omim.org/</td><td>MEIER-GORLIN SYNDROME 1; MGORS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-225753"> </a>OMIM:225753</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-225790"> </a>OMIM:225790</td><td>https://omim.org/</td><td>PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-227650"> </a>OMIM:227650</td><td>https://omim.org/</td><td>FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-229600"> </a>OMIM:229600</td><td>https://omim.org/</td><td>FRUCTOSE INTOLERANCE, HEREDITARY; HFI</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-230000"> </a>OMIM:230000</td><td>https://omim.org/</td><td>FUCOSIDOSIS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-230500"> </a>OMIM:230500</td><td>https://omim.org/</td><td>GM1-GANGLIOSIDOSIS, TYPE I</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-232300"> </a>OMIM:232300</td><td>https://omim.org/</td><td>GLYCOGEN STORAGE DISEASE II; GSD2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-232600"> </a>OMIM:232600</td><td>https://omim.org/</td><td>GLYCOGEN STORAGE DISEASE V; GSD5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-234200"> </a>OMIM:234200</td><td>https://omim.org/</td><td>NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-234500"> </a>OMIM:234500</td><td>https://omim.org/</td><td>HARTNUP DISORDER; HND</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-236000"> </a>OMIM:236000</td><td>https://omim.org/</td><td>LYMPHOMA, HODGKIN, CLASSIC; CHL</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-236600"> </a>OMIM:236600</td><td>https://omim.org/</td><td>HYDROCEPHALUS, CONGENITAL, 1; HYC1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-236792"> </a>OMIM:236792</td><td>https://omim.org/</td><td>L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-243310"> </a>OMIM:243310</td><td>https://omim.org/</td><td>BARAITSER-WINTER SYNDROME 1; BRWS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-244450"> </a>OMIM:244450</td><td>https://omim.org/</td><td>KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-245200"> </a>OMIM:245200</td><td>https://omim.org/</td><td>KRABBE DISEASE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-245359"> </a>OMIM:245359</td><td>https://omim.org/</td><td>missing</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-248200"> </a>OMIM:248200</td><td>https://omim.org/</td><td>STARGARDT DISEASE 1; STGD1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-248700"> </a>OMIM:248700</td><td>https://omim.org/</td><td>MARDEN-WALKER SYNDROME; MWKS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-249000"> </a>OMIM:249000</td><td>https://omim.org/</td><td>MECKEL SYNDROME, TYPE 1; MKS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-249900"> </a>OMIM:249900</td><td>https://omim.org/</td><td>METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-250100"> </a>OMIM:250100</td><td>https://omim.org/</td><td>METACHROMATIC LEUKODYSTROPHY; MLD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-250620"> </a>OMIM:250620</td><td>https://omim.org/</td><td>3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-251200"> </a>OMIM:251200</td><td>https://omim.org/</td><td>MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-251260"> </a>OMIM:251260</td><td>https://omim.org/</td><td>NIJMEGEN BREAKAGE SYNDROME; NBS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-251280"> </a>OMIM:251280</td><td>https://omim.org/</td><td>DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1; DMJDS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-251290"> </a>OMIM:251290</td><td>https://omim.org/</td><td>PSEUDO-TORCH SYNDROME 1; PTORCH1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-251300"> </a>OMIM:251300</td><td>https://omim.org/</td><td>GALLOWAY-MOWAT SYNDROME 1; GAMOS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-252010"> </a>OMIM:252010</td><td>https://omim.org/</td><td>MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-252160"> </a>OMIM:252160</td><td>https://omim.org/</td><td>MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-252920"> </a>OMIM:252920</td><td>https://omim.org/</td><td>MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-253250"> </a>OMIM:253250</td><td>https://omim.org/</td><td>MULIBREY NANISM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-253600"> </a>OMIM:253600</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-253601"> </a>OMIM:253601</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-253700"> </a>OMIM:253700</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-254090"> </a>OMIM:254090</td><td>https://omim.org/</td><td>ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-254110"> </a>OMIM:254110</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8; LGMDR8</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-254300"> </a>OMIM:254300</td><td>https://omim.org/</td><td>MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-254780"> </a>OMIM:254780</td><td>https://omim.org/</td><td>MYOCLONIC EPILEPSY OF LAFORA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-254940"> </a>OMIM:254940</td><td>https://omim.org/</td><td>CAREY-FINEMAN-ZITER SYNDROME; CFZS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-255310"> </a>OMIM:255310</td><td>https://omim.org/</td><td>MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-255320"> </a>OMIM:255320</td><td>https://omim.org/</td><td>MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-255800"> </a>OMIM:255800</td><td>https://omim.org/</td><td>SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256000"> </a>OMIM:256000</td><td>https://omim.org/</td><td>LEIGH SYNDROME; LS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256300"> </a>OMIM:256300</td><td>https://omim.org/</td><td>NEPHROTIC SYNDROME, TYPE 1; NPHS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256600"> </a>OMIM:256600</td><td>https://omim.org/</td><td>NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256700"> </a>OMIM:256700</td><td>https://omim.org/</td><td>NEUROBLASTOMA, SUSCEPTIBILITY TO, 1; NBLST1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256730"> </a>OMIM:256730</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256731"> </a>OMIM:256731</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256800"> </a>OMIM:256800</td><td>https://omim.org/</td><td>INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-256850"> </a>OMIM:256850</td><td>https://omim.org/</td><td>GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-257220"> </a>OMIM:257220</td><td>https://omim.org/</td><td>NIEMANN-PICK DISEASE, TYPE C1; NPC1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-257320"> </a>OMIM:257320</td><td>https://omim.org/</td><td>LISSENCEPHALY 2; LIS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-260400"> </a>OMIM:260400</td><td>https://omim.org/</td><td>SHWACHMAN-DIAMOND SYNDROME 1; SDS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-260565"> </a>OMIM:260565</td><td>https://omim.org/</td><td>PEHO SYNDROME; PEHO</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-261630"> </a>OMIM:261630</td><td>https://omim.org/</td><td>HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-262500"> </a>OMIM:262500</td><td>https://omim.org/</td><td>LARON SYNDROME</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-263200"> </a>OMIM:263200</td><td>https://omim.org/</td><td>POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-265000"> </a>OMIM:265000</td><td>https://omim.org/</td><td>MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-266100"> </a>OMIM:266100</td><td>https://omim.org/</td><td>EPILEPSY, PYRIDOXINE-DEPENDENT; EPD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-266265"> </a>OMIM:266265</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-266500"> </a>OMIM:266500</td><td>https://omim.org/</td><td>REFSUM DISEASE, CLASSIC</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-266510"> </a>OMIM:266510</td><td>https://omim.org/</td><td>PEROXISOME BIOGENESIS DISORDER 3B; PBD3B</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-268800"> </a>OMIM:268800</td><td>https://omim.org/</td><td>SANDHOFF DISEASE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-270200"> </a>OMIM:270200</td><td>https://omim.org/</td><td>SJOGREN-LARSSON SYNDROME; SLS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-270800"> </a>OMIM:270800</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-271900"> </a>OMIM:271900</td><td>https://omim.org/</td><td>CANAVAN DISEASE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-272800"> </a>OMIM:272800</td><td>https://omim.org/</td><td>TAY-SACHS DISEASE; TSD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-273300"> </a>OMIM:273300</td><td>https://omim.org/</td><td>TESTICULAR GERM CELL TUMOR; TGCT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-274000"> </a>OMIM:274000</td><td>https://omim.org/</td><td>THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-276901"> </a>OMIM:276901</td><td>https://omim.org/</td><td>USHER SYNDROME, TYPE IIA; USH2A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-277470"> </a>OMIM:277470</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300029"> </a>OMIM:300029</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 3; RP3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300067"> </a>OMIM:300067</td><td>https://omim.org/</td><td>LISSENCEPHALY, X-LINKED, 1; LISX1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300088"> </a>OMIM:300088</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9; DEE9</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300100"> </a>OMIM:300100</td><td>https://omim.org/</td><td>ADRENOLEUKODYSTROPHY; ALD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300376"> </a>OMIM:300376</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, BECKER TYPE; BMD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300387"> </a>OMIM:300387</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED 63; MRX63</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300476"> </a>OMIM:300476</td><td>https://omim.org/</td><td>CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300486"> </a>OMIM:300486</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300495"> </a>OMIM:300495</td><td>https://omim.org/</td><td>AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300523"> </a>OMIM:300523</td><td>https://omim.org/</td><td>ALLAN-HERNDON-DUDLEY SYNDROME; AHDS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300534"> </a>OMIM:300534</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300695"> </a>OMIM:300695</td><td>https://omim.org/</td><td>SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300749"> </a>OMIM:300749</td><td>https://omim.org/</td><td>MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300804"> </a>OMIM:300804</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 10; JBTS10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300881"> </a>OMIM:300881</td><td>https://omim.org/</td><td>MOVED TO 615777</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300882"> </a>OMIM:300882</td><td>https://omim.org/</td><td>CORNELIA DE LANGE SYNDROME 5; CDLS5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300894"> </a>OMIM:300894</td><td>https://omim.org/</td><td>NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300908"> </a>OMIM:300908</td><td>https://omim.org/</td><td>ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300957"> </a>OMIM:300957</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED 12; MRX12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300958"> </a>OMIM:300958</td><td>https://omim.org/</td><td>INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300966"> </a>OMIM:300966</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED, SYNDROMIC 33; MRXS33</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300968"> </a>OMIM:300968</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300983"> </a>OMIM:300983</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED 104; MRX104</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-300986"> </a>OMIM:300986</td><td>https://omim.org/</td><td>MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-301050"> </a>OMIM:301050</td><td>https://omim.org/</td><td>ALPORT SYNDROME 1, X-LINKED; ATS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-301310"> </a>OMIM:301310</td><td>https://omim.org/</td><td>ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-304340"> </a>OMIM:304340</td><td>https://omim.org/</td><td>PETTIGREW SYNDROME; PGS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-305100"> </a>OMIM:305100</td><td>https://omim.org/</td><td>ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-308350"> </a>OMIM:308350</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-309500"> </a>OMIM:309500</td><td>https://omim.org/</td><td>RENPENNING SYNDROME 1; RENS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-309541"> </a>OMIM:309541</td><td>https://omim.org/</td><td>METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-309580"> </a>OMIM:309580</td><td>https://omim.org/</td><td>MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-310468"> </a>OMIM:310468</td><td>https://omim.org/</td><td>NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-311070"> </a>OMIM:311070</td><td>https://omim.org/</td><td>CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-313850"> </a>OMIM:313850</td><td>https://omim.org/</td><td>THORACOABDOMINAL SYNDROME; THAS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-314580"> </a>OMIM:314580</td><td>https://omim.org/</td><td>WIEACKER-WOLFF SYNDROME; WRWF</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600059"> </a>OMIM:600059</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 13; RP13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600105"> </a>OMIM:600105</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 12; RP12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600118"> </a>OMIM:600118</td><td>https://omim.org/</td><td>WARBURG MICRO SYNDROME 1; WARBM1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600132"> </a>OMIM:600132</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 14; RP14</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600138"> </a>OMIM:600138</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 11; RP11</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600143"> </a>OMIM:600143</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600334"> </a>OMIM:600334</td><td>https://omim.org/</td><td>TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600373"> </a>OMIM:600373</td><td>https://omim.org/</td><td>CODAS SYNDROME</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600618"> </a>OMIM:600618</td><td>https://omim.org/</td><td>ETS VARIANT GENE 6; ETV6</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-600995"> </a>OMIM:600995</td><td>https://omim.org/</td><td>NEPHROTIC SYNDROME, TYPE 2; NPHS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601088"> </a>OMIM:601088</td><td>https://omim.org/</td><td>AYME-GRIPP SYNDROME; AYGRP</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601414"> </a>OMIM:601414</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 18; RP18</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601419"> </a>OMIM:601419</td><td>https://omim.org/</td><td>MYOPATHY, MYOFIBRILLAR, 1; MFM1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601680"> </a>OMIM:601680</td><td>https://omim.org/</td><td>ARTHROGRYPOSIS, DISTAL, TYPE 2B1; DA2B1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601718"> </a>OMIM:601718</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 19; RP19</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601780"> </a>OMIM:601780</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601815"> </a>OMIM:601815</td><td>https://omim.org/</td><td>PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-601954"> </a>OMIM:601954</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7; LGMDR7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-602482"> </a>OMIM:602482</td><td>https://omim.org/</td><td>AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-602579"> </a>OMIM:602579</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-602772"> </a>OMIM:602772</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 25; RP25</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-603511"> </a>OMIM:603511</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1; LGMDD1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-603896"> </a>OMIM:603896</td><td>https://omim.org/</td><td>LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604004"> </a>OMIM:604004</td><td>https://omim.org/</td><td>MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604116"> </a>OMIM:604116</td><td>https://omim.org/</td><td>CONE-ROD DYSTROPHY 3; CORD3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604273"> </a>OMIM:604273</td><td>https://omim.org/</td><td>MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604286"> </a>OMIM:604286</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604317"> </a>OMIM:604317</td><td>https://omim.org/</td><td>MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604360"> </a>OMIM:604360</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604387"> </a>OMIM:604387</td><td>https://omim.org/</td><td>NEPHRONOPHTHISIS 3; NPHP3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604537"> </a>OMIM:604537</td><td>https://omim.org/</td><td>LEBER CONGENITAL AMAUROSIS 5; LCA5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-604592"> </a>OMIM:604592</td><td>https://omim.org/</td><td>T CELL IMMUNE REGULATOR 1; TCIRG1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-605130"> </a>OMIM:605130</td><td>https://omim.org/</td><td>WIEDEMANN-STEINER SYNDROME; WDSTS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-605355"> </a>OMIM:605355</td><td>https://omim.org/</td><td>NEMALINE MYOPATHY 5; NEM5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-605407"> </a>OMIM:605407</td><td>https://omim.org/</td><td>SEGAWA SYNDROME, AUTOSOMAL RECESSIVE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-605637"> </a>OMIM:605637</td><td>https://omim.org/</td><td>MYOPATHY, PROXIMAL, WITH OPHTHALMOPLEGIA; MYPOP</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-605670"> </a>OMIM:605670</td><td>https://omim.org/</td><td>LATE-ONSET RETINAL DEGENERATION; LORD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-605820"> </a>OMIM:605820</td><td>https://omim.org/</td><td>NONAKA MYOPATHY; NM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-605899"> </a>OMIM:605899</td><td>https://omim.org/</td><td>GLYCINE ENCEPHALOPATHY; GCE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-606068"> </a>OMIM:606068</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 28; RP28</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-606170"> </a>OMIM:606170</td><td>https://omim.org/</td><td>GENITOPATELLAR SYNDROME; GTPTS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-606232"> </a>OMIM:606232</td><td>https://omim.org/</td><td>PHELAN-MCDERMID SYNDROME; PHMDS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-606777"> </a>OMIM:606777</td><td>https://omim.org/</td><td>GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-606854"> </a>OMIM:606854</td><td>https://omim.org/</td><td>POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-606966"> </a>OMIM:606966</td><td>https://omim.org/</td><td>NEPHRONOPHTHISIS 4; NPHP4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-606996"> </a>OMIM:606996</td><td>https://omim.org/</td><td>SENIOR-LOKEN SYNDROME 4; SLSN4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607015"> </a>OMIM:607015</td><td>https://omim.org/</td><td>HURLER-SCHEIE SYNDROME</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607155"> </a>OMIM:607155</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607196"> </a>OMIM:607196</td><td>https://omim.org/</td><td>MICROCEPHALY, AMISH TYPE; MCPHA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607225"> </a>OMIM:607225</td><td>https://omim.org/</td><td>SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607426"> </a>OMIM:607426</td><td>https://omim.org/</td><td>COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607432"> </a>OMIM:607432</td><td>https://omim.org/</td><td>LISSENCEPHALY 1; LIS1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607483"> </a>OMIM:607483</td><td>https://omim.org/</td><td>THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607595"> </a>OMIM:607595</td><td>https://omim.org/</td><td>MOVED TO 175780</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607596"> </a>OMIM:607596</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-607855"> </a>OMIM:607855</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608027"> </a>OMIM:608027</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608091"> </a>OMIM:608091</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 2; JBTS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608099"> </a>OMIM:608099</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608133"> </a>OMIM:608133</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 7; RP7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608358"> </a>OMIM:608358</td><td>https://omim.org/</td><td>MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608380"> </a>OMIM:608380</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 26; RP26</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608393"> </a>OMIM:608393</td><td>https://omim.org/</td><td>MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608415"> </a>OMIM:608415</td><td>https://omim.org/</td><td>PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608423"> </a>OMIM:608423</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608540"> </a>OMIM:608540</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608629"> </a>OMIM:608629</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 3; JBTS3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608643"> </a>OMIM:608643</td><td>https://omim.org/</td><td>AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608716"> </a>OMIM:608716</td><td>https://omim.org/</td><td>MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608804"> </a>OMIM:608804</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-608807"> </a>OMIM:608807</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609033"> </a>OMIM:609033</td><td>https://omim.org/</td><td>POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609056"> </a>OMIM:609056</td><td>https://omim.org/</td><td>SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609195"> </a>OMIM:609195</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609200"> </a>OMIM:609200</td><td>https://omim.org/</td><td>MYOPATHY, MYOFIBRILLAR, 3; MFM3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609260"> </a>OMIM:609260</td><td>https://omim.org/</td><td>CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609270"> </a>OMIM:609270</td><td>https://omim.org/</td><td>SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609304"> </a>OMIM:609304</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3; DEE3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609524"> </a>OMIM:609524</td><td>https://omim.org/</td><td>MYOPATHY, MYOFIBRILLAR, 5; MFM5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609560"> </a>OMIM:609560</td><td>https://omim.org/</td><td>MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-609923"> </a>OMIM:609923</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 31; RP31</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610019"> </a>OMIM:610019</td><td>https://omim.org/</td><td>CATARACT 18; CTRCT18</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610031"> </a>OMIM:610031</td><td>https://omim.org/</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610127"> </a>OMIM:610127</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610181"> </a>OMIM:610181</td><td>https://omim.org/</td><td>AICARDI-GOUTIERES SYNDROME 2; AGS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610188"> </a>OMIM:610188</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 5; JBTS5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610217"> </a>OMIM:610217</td><td>https://omim.org/</td><td>NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610329"> </a>OMIM:610329</td><td>https://omim.org/</td><td>AICARDI-GOUTIERES SYNDROME 3; AGS3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610333"> </a>OMIM:610333</td><td>https://omim.org/</td><td>AICARDI-GOUTIERES SYNDROME 4; AGS4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610359"> </a>OMIM:610359</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 33; RP33</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610443"> </a>OMIM:610443</td><td>https://omim.org/</td><td>KOOLEN-DE VRIES SYNDROME; KDVS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610444"> </a>OMIM:610444</td><td>https://omim.org/</td><td>NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610489"> </a>OMIM:610489</td><td>https://omim.org/</td><td>PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610532"> </a>OMIM:610532</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610688"> </a>OMIM:610688</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 6; JBTS6</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610725"> </a>OMIM:610725</td><td>https://omim.org/</td><td>NEPHROTIC SYNDROME, TYPE 3; NPHS3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-610951"> </a>OMIM:610951</td><td>https://omim.org/</td><td>CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611091"> </a>OMIM:611091</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611302"> </a>OMIM:611302</td><td>https://omim.org/</td><td>SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611307"> </a>OMIM:611307</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611560"> </a>OMIM:611560</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 7; JBTS7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611603"> </a>OMIM:611603</td><td>https://omim.org/</td><td>LISSENCEPHALY 3; LIS3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611705"> </a>OMIM:611705</td><td>https://omim.org/</td><td>SALIH MYOPATHY; SALMY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611721"> </a>OMIM:611721</td><td>https://omim.org/</td><td>COMBINED SAPOSIN DEFICIENCY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611726"> </a>OMIM:611726</td><td>https://omim.org/</td><td>EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-611755"> </a>OMIM:611755</td><td>https://omim.org/</td><td>LEBER CONGENITAL AMAUROSIS 10; LCA10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612015"> </a>OMIM:612015</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612095"> </a>OMIM:612095</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 41; RP41</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612126"> </a>OMIM:612126</td><td>https://omim.org/</td><td>GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612285"> </a>OMIM:612285</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 9; JBTS9</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612337"> </a>OMIM:612337</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612370"> </a>OMIM:612370</td><td>https://omim.org/</td><td>HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612438"> </a>OMIM:612438</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612528"> </a>OMIM:612528</td><td>https://omim.org/</td><td>DIAMOND-BLACKFAN ANEMIA 5; DBA5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612621"> </a>OMIM:612621</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612712"> </a>OMIM:612712</td><td>https://omim.org/</td><td>LEBER CONGENITAL AMAUROSIS 13; LCA13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612716"> </a>OMIM:612716</td><td>https://omim.org/</td><td>DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612780"> </a>OMIM:612780</td><td>https://omim.org/</td><td>SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612936"> </a>OMIM:612936</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612943"> </a>OMIM:612943</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 42; RP42</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-612951"> </a>OMIM:612951</td><td>https://omim.org/</td><td>LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613065"> </a>OMIM:613065</td><td>https://omim.org/</td><td>LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613091"> </a>OMIM:613091</td><td>https://omim.org/</td><td>SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613155"> </a>OMIM:613155</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL IMPAIRMENT), TYPE B, 1; MDDGB1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613156"> </a>OMIM:613156</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; MDDGB2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613158"> </a>OMIM:613158</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613192"> </a>OMIM:613192</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613205"> </a>OMIM:613205</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613216"> </a>OMIM:613216</td><td>https://omim.org/</td><td>NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613217"> </a>OMIM:613217</td><td>https://omim.org/</td><td>DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613402"> </a>OMIM:613402</td><td>https://omim.org/</td><td>MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613428"> </a>OMIM:613428</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 54; RP54</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613454"> </a>OMIM:613454</td><td>https://omim.org/</td><td>RETT SYNDROME, CONGENITAL VARIANT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613550"> </a>OMIM:613550</td><td>https://omim.org/</td><td>NEPHRONOPHTHISIS 11; NPHP11</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613561"> </a>OMIM:613561</td><td>https://omim.org/</td><td>MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613587"> </a>OMIM:613587</td><td>https://omim.org/</td><td>OCCULT MACULAR DYSTROPHY; OCMD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613612"> </a>OMIM:613612</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613660"> </a>OMIM:613660</td><td>https://omim.org/</td><td>CONE-ROD DYSTROPHY 15; CORD15</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613668"> </a>OMIM:613668</td><td>https://omim.org/</td><td>MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613680"> </a>OMIM:613680</td><td>https://omim.org/</td><td>BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613684"> </a>OMIM:613684</td><td>https://omim.org/</td><td>RUBINSTEIN-TAYBI SYNDROME 2; RSTS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613690"> </a>OMIM:613690</td><td>https://omim.org/</td><td>CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613706"> </a>OMIM:613706</td><td>https://omim.org/</td><td>NOONAN SYNDROME 7; NS7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613722"> </a>OMIM:613722</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12; DEE12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613731"> </a>OMIM:613731</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 4; RP4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613744"> </a>OMIM:613744</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613750"> </a>OMIM:613750</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 27; RP27</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613756"> </a>OMIM:613756</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 49; RP49</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613767"> </a>OMIM:613767</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 45; RP45</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613794"> </a>OMIM:613794</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 20; RP20</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613809"> </a>OMIM:613809</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 39; RP39</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613810"> </a>OMIM:613810</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 43; RP43</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613811"> </a>OMIM:613811</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613820"> </a>OMIM:613820</td><td>https://omim.org/</td><td>NEPHRONOPHTHISIS 12; NPHP12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613835"> </a>OMIM:613835</td><td>https://omim.org/</td><td>LEBER CONGENITAL AMAUROSIS 8; LCA8</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613861"> </a>OMIM:613861</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 59; RP59</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-613862"> </a>OMIM:613862</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 38; RP38</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614034"> </a>OMIM:614034</td><td>https://omim.org/</td><td>HEME OXYGENASE 1 DEFICIENCY; HMOX1D</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614065"> </a>OMIM:614065</td><td>https://omim.org/</td><td>MYOPATHY, DISTAL, 4; MPD4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614173"> </a>OMIM:614173</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 13; JBTS13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614180"> </a>OMIM:614180</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 61; RP61</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614181"> </a>OMIM:614181</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 62; RP62</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614199"> </a>OMIM:614199</td><td>https://omim.org/</td><td>NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614202"> </a>OMIM:614202</td><td>https://omim.org/</td><td>RAFIQ SYNDROME; RAFQS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614225"> </a>OMIM:614225</td><td>https://omim.org/</td><td>WARBURG MICRO SYNDROME 2; WARBM2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614254"> </a>OMIM:614254</td><td>https://omim.org/</td><td>NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614255"> </a>OMIM:614255</td><td>https://omim.org/</td><td>NESCAV SYNDROME; NESCAVS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614299"> </a>OMIM:614299</td><td>https://omim.org/</td><td>MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614381"> </a>OMIM:614381</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614424"> </a>OMIM:614424</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 14; JBTS14</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614500"> </a>OMIM:614500</td><td>https://omim.org/</td><td>CONE-ROD DYSTROPHY 16; CORD16</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614557"> </a>OMIM:614557</td><td>https://omim.org/</td><td>EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614607"> </a>OMIM:614607</td><td>https://omim.org/</td><td>COFFIN-SIRIS SYNDROME 2; CSS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614615"> </a>OMIM:614615</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 17; JBTS17</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614669"> </a>OMIM:614669</td><td>https://omim.org/</td><td>AURICULOCONDYLAR SYNDROME 2; ARCND2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614678"> </a>OMIM:614678</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614744"> </a>OMIM:614744</td><td>https://omim.org/</td><td>FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614753"> </a>OMIM:614753</td><td>https://omim.org/</td><td>SOTOS SYNDROME 2; SOTOS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614831"> </a>OMIM:614831</td><td>https://omim.org/</td><td>SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614833"> </a>OMIM:614833</td><td>https://omim.org/</td><td>MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614876"> </a>OMIM:614876</td><td>https://omim.org/</td><td>PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614877"> </a>OMIM:614877</td><td>https://omim.org/</td><td>PEROXISOME BIOGENESIS DISORDER 8B; PBD8B</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614932"> </a>OMIM:614932</td><td>https://omim.org/</td><td>COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614945"> </a>OMIM:614945</td><td>https://omim.org/</td><td>DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615030"> </a>OMIM:615030</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615031"> </a>OMIM:615031</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615065"> </a>OMIM:615065</td><td>https://omim.org/</td><td>ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615071"> </a>OMIM:615071</td><td>https://omim.org/</td><td>ALAZAMI SYNDROME; ALAZS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615095"> </a>OMIM:615095</td><td>https://omim.org/</td><td>MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615181"> </a>OMIM:615181</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615190"> </a>OMIM:615190</td><td>https://omim.org/</td><td>DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615191"> </a>OMIM:615191</td><td>https://omim.org/</td><td>LISSENCEPHALY 5; LIS5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615268"> </a>OMIM:615268</td><td>https://omim.org/</td><td>CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615286"> </a>OMIM:615286</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615352"> </a>OMIM:615352</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615411"> </a>OMIM:615411</td><td>https://omim.org/</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615412"> </a>OMIM:615412</td><td>https://omim.org/</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615419"> </a>OMIM:615419</td><td>https://omim.org/</td><td>HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615471"> </a>OMIM:615471</td><td>https://omim.org/</td><td>MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615476"> </a>OMIM:615476</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18; DEE18</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615485"> </a>OMIM:615485</td><td>https://omim.org/</td><td>BAINBRIDGE-ROPERS SYNDROME; BRPS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615502"> </a>OMIM:615502</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615546"> </a>OMIM:615546</td><td>https://omim.org/</td><td>VAN MALDERGEM SYNDROME 2; VMLDS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615574"> </a>OMIM:615574</td><td>https://omim.org/</td><td>ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615681"> </a>OMIM:615681</td><td>https://omim.org/</td><td>SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE; SPG62</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615715"> </a>OMIM:615715</td><td>https://omim.org/</td><td>BONE MARROW FAILURE SYNDROME 2; BMFS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615716"> </a>OMIM:615716</td><td>https://omim.org/</td><td>HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615760"> </a>OMIM:615760</td><td>https://omim.org/</td><td>MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615763"> </a>OMIM:615763</td><td>https://omim.org/</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615809"> </a>OMIM:615809</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615829"> </a>OMIM:615829</td><td>https://omim.org/</td><td>XIA-GIBBS SYNDROME; XIGIS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615834"> </a>OMIM:615834</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615846"> </a>OMIM:615846</td><td>https://omim.org/</td><td>AICARDI-GOUTIERES SYNDROME 7; AGS7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615866"> </a>OMIM:615866</td><td>https://omim.org/</td><td>COFFIN-SIRIS SYNDROME 9; CSS9</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615909"> </a>OMIM:615909</td><td>https://omim.org/</td><td>DIAMOND-BLACKFAN ANEMIA 13; DBA13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615948"> </a>OMIM:615948</td><td>https://omim.org/</td><td>OROFACIODIGITAL SYNDROME XIV; OFD14</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615959"> </a>OMIM:615959</td><td>https://omim.org/</td><td>MYOPATHY, CENTRONUCLEAR, 5; CNM5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615960"> </a>OMIM:615960</td><td>https://omim.org/</td><td>PORETTI-BOLTSHAUSER SYNDROME; PTBHS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615973"> </a>OMIM:615973</td><td>https://omim.org/</td><td>CONE-ROD DYSTROPHY 20; CORD20</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615981"> </a>OMIM:615981</td><td>https://omim.org/</td><td>BARDET-BIEDL SYNDROME 2; BBS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615982"> </a>OMIM:615982</td><td>https://omim.org/</td><td>BARDET-BIEDL SYNDROME 4; BBS4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615983"> </a>OMIM:615983</td><td>https://omim.org/</td><td>BARDET-BIEDL SYNDROME 5; BBS5</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-615993"> </a>OMIM:615993</td><td>https://omim.org/</td><td>BARDET-BIEDL SYNDROME 16; BBS16</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616051"> </a>OMIM:616051</td><td>https://omim.org/</td><td>MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616056"> </a>OMIM:616056</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26; DEE26</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616081"> </a>OMIM:616081</td><td>https://omim.org/</td><td>PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616094"> </a>OMIM:616094</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616127"> </a>OMIM:616127</td><td>https://omim.org/</td><td>SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616140"> </a>OMIM:616140</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616155"> </a>OMIM:616155</td><td>https://omim.org/</td><td>CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616171"> </a>OMIM:616171</td><td>https://omim.org/</td><td>MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616199"> </a>OMIM:616199</td><td>https://omim.org/</td><td>POLYGLUCOSAN BODY MYOPATHY 2; PGBM2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616211"> </a>OMIM:616211</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28; DEE28</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616263"> </a>OMIM:616263</td><td>https://omim.org/</td><td>NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616266"> </a>OMIM:616266</td><td>https://omim.org/</td><td>CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616271"> </a>OMIM:616271</td><td>https://omim.org/</td><td>3-METHYLGLUTACONIC ACIDURIA, TYPE VII; MGCA7</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616277"> </a>OMIM:616277</td><td>https://omim.org/</td><td>MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616281"> </a>OMIM:616281</td><td>https://omim.org/</td><td>NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY; NEDSPM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616321"> </a>OMIM:616321</td><td>https://omim.org/</td><td>MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616354"> </a>OMIM:616354</td><td>https://omim.org/</td><td>SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616394"> </a>OMIM:616394</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 71; RP71</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616420"> </a>OMIM:616420</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616421"> </a>OMIM:616421</td><td>https://omim.org/</td><td>MYOCLONIC-ATONIC EPILEPSY; MAE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616471"> </a>OMIM:616471</td><td>https://omim.org/</td><td>BETHLEM MYOPATHY 2; BTHLM2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616490"> </a>OMIM:616490</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 23; JBTS23</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616531"> </a>OMIM:616531</td><td>https://omim.org/</td><td>POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616544"> </a>OMIM:616544</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 73; RP73</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616562"> </a>OMIM:616562</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 74; RP74</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616564"> </a>OMIM:616564</td><td>https://omim.org/</td><td>NOONAN SYNDROME 10; NS10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616632"> </a>OMIM:616632</td><td>https://omim.org/</td><td>SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616647"> </a>OMIM:616647</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35; DEE35</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616649"> </a>OMIM:616649</td><td>https://omim.org/</td><td>SPHEROCYTOSIS, TYPE 2; SPH2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616651"> </a>OMIM:616651</td><td>https://omim.org/</td><td>ROIFMAN SYNDROME; RFMN</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616654"> </a>OMIM:616654</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 24; JBTS24</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616657"> </a>OMIM:616657</td><td>https://omim.org/</td><td>SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616668"> </a>OMIM:616668</td><td>https://omim.org/</td><td>CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616683"> </a>OMIM:616683</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616721"> </a>OMIM:616721</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616732"> </a>OMIM:616732</td><td>https://omim.org/</td><td>OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616738"> </a>OMIM:616738</td><td>https://omim.org/</td><td>RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616740"> </a>OMIM:616740</td><td>https://omim.org/</td><td>IMMUNODEFICIENCY 46; IMD46</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616789"> </a>OMIM:616789</td><td>https://omim.org/</td><td>MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616801"> </a>OMIM:616801</td><td>https://omim.org/</td><td>HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616875"> </a>OMIM:616875</td><td>https://omim.org/</td><td>CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616892"> </a>OMIM:616892</td><td>https://omim.org/</td><td>NEPHROTIC SYNDROME, TYPE 12; NPHS12</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616900"> </a>OMIM:616900</td><td>https://omim.org/</td><td>HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-616973"> </a>OMIM:616973</td><td>https://omim.org/</td><td>MENTAL RETARDATION, AUTOSOMAL DOMINANT 42; MRD42</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617011"> </a>OMIM:617011</td><td>https://omim.org/</td><td>MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617013"> </a>OMIM:617013</td><td>https://omim.org/</td><td>HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617047"> </a>OMIM:617047</td><td>https://omim.org/</td><td>CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617052"> </a>OMIM:617052</td><td>https://omim.org/</td><td>BONE MARROW FAILURE SYNDROME 3; BMFS3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617053"> </a>OMIM:617053</td><td>https://omim.org/</td><td>MIRAGE SYNDROME; MIRAGE</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617093"> </a>OMIM:617093</td><td>https://omim.org/</td><td>GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617106"> </a>OMIM:617106</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42; DEE42</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617120"> </a>OMIM:617120</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 27; JBTS27</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617121"> </a>OMIM:617121</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 28; JBTS28</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617123"> </a>OMIM:617123</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 76; RP76</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617137"> </a>OMIM:617137</td><td>https://omim.org/</td><td>FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617146"> </a>OMIM:617146</td><td>https://omim.org/</td><td>ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617183"> </a>OMIM:617183</td><td>https://omim.org/</td><td>HAREL-YOON SYNDROME; HAYOS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617193"> </a>OMIM:617193</td><td>https://omim.org/</td><td>ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617222"> </a>OMIM:617222</td><td>https://omim.org/</td><td>SUDDEN CARDIAC FAILURE, INFANTILE; SCFI</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617276"> </a>OMIM:617276</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48; DEE48</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617330"> </a>OMIM:617330</td><td>https://omim.org/</td><td>HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617350"> </a>OMIM:617350</td><td>https://omim.org/</td><td>DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52; DEE52</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617397"> </a>OMIM:617397</td><td>https://omim.org/</td><td>PSEUDO-TORCH SYNDROME 2; PTORCH2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617433"> </a>OMIM:617433</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 78; RP78</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617443"> </a>OMIM:617443</td><td>https://omim.org/</td><td>BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617460"> </a>OMIM:617460</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 79; RP79</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617481"> </a>OMIM:617481</td><td>https://omim.org/</td><td>NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617537"> </a>OMIM:617537</td><td>https://omim.org/</td><td>RAHMAN SYNDROME; RMNS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617547"> </a>OMIM:617547</td><td>https://omim.org/</td><td>RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617622"> </a>OMIM:617622</td><td>https://omim.org/</td><td>JOUBERT SYNDROME 30; JBTS30</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617675"> </a>OMIM:617675</td><td>https://omim.org/</td><td>MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617681"> </a>OMIM:617681</td><td>https://omim.org/</td><td>BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617694"> </a>OMIM:617694</td><td>https://omim.org/</td><td>AL KAISSI SYNDROME; ALKAS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617781"> </a>OMIM:617781</td><td>https://omim.org/</td><td>RETINITIS PIGMENTOSA 80; RP80</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617805"> </a>OMIM:617805</td><td>https://omim.org/</td><td>RENAL HYPODYSPLASIA/APLASIA 3; RHDA3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617807"> </a>OMIM:617807</td><td>https://omim.org/</td><td>NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617829"> </a>OMIM:617829</td><td>https://omim.org/</td><td>EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617873"> </a>OMIM:617873</td><td>https://omim.org/</td><td>COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617948"> </a>OMIM:617948</td><td>https://omim.org/</td><td>ELLIPTOCYTOSIS 3; EL3</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-617954"> </a>OMIM:617954</td><td>https://omim.org/</td><td>MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618056"> </a>OMIM:618056</td><td>https://omim.org/</td><td>NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618088"> </a>OMIM:618088</td><td>https://omim.org/</td><td>NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618129"> </a>OMIM:618129</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618138"> </a>OMIM:618138</td><td>https://omim.org/</td><td>MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618174"> </a>OMIM:618174</td><td>https://omim.org/</td><td>CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618225"> </a>OMIM:618225</td><td>https://omim.org/</td><td>MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618273"> </a>OMIM:618273</td><td>https://omim.org/</td><td>MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618316"> </a>OMIM:618316</td><td>https://omim.org/</td><td>INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618325"> </a>OMIM:618325</td><td>https://omim.org/</td><td>LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618404"> </a>OMIM:618404</td><td>https://omim.org/</td><td>LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-618512"> </a>OMIM:618512</td><td>https://omim.org/</td><td>O\'DONNELL-LURIA-RODAN SYNDROME; ODLURO</td><td/></tr><tr><td style="white-space:nowrap"><a name="https---omim.org--OMIM-614921"> </a>OMIM:614921</td><td>https://omim.org/</td><td>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T</td><td/></tr><tr><td style="white-space:nowrap"><a name="http---purl.obolibrary.org-obo-mondo.owl-MONDO-0005072"> </a>MONDO:0005072</td><td>http://purl.obolibrary.org/obo/mondo.owl</td><td>neuroblastoma</td><td/></tr><tr><td style="white-space:nowrap"><a name="http---purl.obolibrary.org-obo-mondo.owl-MONDO-0002749"> </a>MONDO:0002749</td><td>http://purl.obolibrary.org/obo/mondo.owl</td><td>extracranial neuroblastoma</td><td/></tr><tr><td style="white-space:nowrap"><a name="http---purl.obolibrary.org-obo-mondo.owl-MONDO-0008542"> </a>MONDO:0008542</td><td>http://purl.obolibrary.org/obo/mondo.owl</td><td>tetralogy of fallot</td><td/></tr><tr><td style="white-space:nowrap"><a name="http---purl.obolibrary.org-obo-ncit.owl-C3270"> </a>C3270</td><td>http://purl.obolibrary.org/obo/ncit.owl</td><td>Neuroblastoma</td><td/></tr><tr><td style="white-space:nowrap"><a name="http---purl.obolibrary.org-obo-ncit.owl-C5437"> </a>C5437</td><td>http://purl.obolibrary.org/obo/ncit.owl</td><td>Extracranial Neuroblastoma</td><td/></tr><tr><td style="white-space:nowrap"><a name="http---purl.obolibrary.org-obo-ncit.owl-C84505"> </a>C84505</td><td>http://purl.obolibrary.org/obo/ncit.owl</td><td>Tetralogy of Fallot</td><td/></tr></table></div>

  <hr/>
  <p>
    Explanation of the columns that may appear on this page:
  </p>
  <table class="grid">
    <tr>
      <td>Level</td>
      <td>A few code lists that FHIR defines are hierarchical - each code is assigned a level.
          In this scheme, some codes are under other codes, and imply that the code they are under also applies</td>
    </tr>
    <tr>
      <td>Source</td>
      <td>The source of the definition of the code (when the value set draws in codes defined elsewhere)</td>
    </tr>
    <tr>
      <td>Code</td>
      <td>The code (used as the code in the resource instance)</td>
    </tr>
    <tr>
      <td>Display</td>
      <td>The display (used in the <i>display</i> element of a <a href="http://hl7.org/fhir/R4/datatypes.html#Coding">Coding</a>). If there is no display, implementers should not simply display the code, but map the concept into their application</td>
    </tr>
    <tr>
      <td>Definition</td>
      <td>An explanation of the meaning of the concept</td>
    </tr>
    <tr>
      <td>Comments</td>
      <td>Additional notes about how to use the code</td>
    </tr>
  </table>

  <!-- insert notes if present -->
  



  

</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2021+ <a style="color:var(--footer-hyperlink-text-color)" href="https://github.com/ncpi-fhir">NCPI FHIR Working Group</a>.  Package NCPI-FHIR-Implementation-Guide#0.1.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Tue, Sep 14, 2021 17:59+0000">2021-09-14</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)"></span>
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                
          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->
  
  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>
  
<!-- feedback form - Google forms -->
<!-- v0.1, 2021-01-09 -->



<!-- / feedback form  -->

  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

